MyAverix Finance
SHG · Healthcare
Lionco Pharm Grp Co Ltd (603669)
Drug Manufacturers - Specialty & Generic
Lionco Pharm Grp Co Ltd (603669) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $3.25B, P/E ratio is 18.00, net margin is -27.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603669
Lionco Pharm Grp Co Ltd (603669) — FAQ
What is Lionco Pharm Grp Co Ltd's market cap?
Lionco Pharm Grp Co Ltd (603669) has a reported market cap of $3.25B (data as of 2026-03-29).
What is 603669's P/E ratio?
The price-to-earnings (P/E) ratio for Lionco Pharm Grp Co Ltd (603669) is 18.00 (data as of 2026-03-29).
Does Lionco Pharm Grp Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Lionco Pharm Grp Co Ltd (603669). Check the MyAverix Finance app for the latest dividend data.
What sector is Lionco Pharm Grp Co Ltd in?
Lionco Pharm Grp Co Ltd (603669) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603669 listed on?
603669 is listed on SHG.
What is Lionco Pharm Grp Co Ltd's net margin?
Lionco Pharm Grp Co Ltd (603669) reports a net margin of -27.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.